Florida Cancer Specialists & Research Institute Chief Medical Officer Shares Spotlight with Global Innovators in Genomic Health Fort Myers, Fla., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Lucio Gordan, MD, Chief Medical Officer of Therapeutics & Analytics for Florida Cancer Specialists & Research Institute, LLC (FCS), is a...

Florida Cancer Specialists & Research Institute Celebrates Addition of Next-Generation Genomic Testing Capabilities to Advance Precision Oncology Approach to Patient Care Fort Myers, Fla., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Florida Cancer Specialists & Research Institute, LLC (FCS) celebrated the addition of genomic testing capabilities at its Next Generation...

Molecular Diagnostics Point of Care Market Size to Reach USD 4.84 Billion in 2027 | Increasing Prevalence of Infectious Diseases and Rising Demand for Diagnostics Point-Of-Care are Key Factors Driving Industry Growth, says Emergen Research Vancouver, British Columbia, April 08, 2021 (GLOBE NEWSWIRE) -- The global molecular diagnostics point of care market size is expected to reach USD 4.84 Billion in 2027 and register a robust revenue...

Azzad Asset Management launches Shariah-compliant disruptive innovation portfolio Falls Church, Virginia, Feb. 02, 2021 (GLOBE NEWSWIRE) -- Registered investment advisor Azzad Asset Management announced today a new investment portfolio aimed at capitalizing on macro trends in...

Admera Health Reaches Significant Major Milestone in Achieving New York Department of CLEP Approval for PGxOne™ Plus, a 25 Gene Pharmacogenomics Test SOUTH PLAINFIELD, N.J., Nov. 01, 2016 (GLOBE NEWSWIRE) -- Molecular Diagnostics company, Admera Health, (www.admerahealth.com) announced today that it received New York State Clinical Laboratory...